Archives: Speakers

Steve is a Lead Analyst within Global Data’s Financial Services Practice responsible for Fintech and Thematic content. His research covers all areas of digital transformation strategy from both a customer and technology perspective, with a particular focus on disruptive new business models. Prior to GD, Steve spent time at Forrester and Gartner, and within Strategy roles at Lloyds bank.

Priya Chaturvedi is Vice President, Head of Global Clinical Quality at Eisai Pharmaceutical based in USA. She has responsibility for Global Clinical Quality Assurance and Global Process and Standards. She joined Eisai in 2019. Prior to that, she was Executive Director, CQA at Merck. Before Merck, she was at Pfizer in Quality roles within clinical and medical affairs. Prior to joining Pfizer, Priya spent 12 years at GSK in different clinical, project management and discovery roles.

She received her doctorate from Temple University, School of Medicine, PA.

Best-selling author, leading researcher, and global speaker: Dr. Brittany Barreto dedicates her work to advancing women’s health innovation by equipping key stakeholders with data-driven insights and strategic advice on the femhealth market. She earned a doctorate in Molecular and Human Genetics from Baylor College of Medicine, founded several tech startups, and championed dozens of investments while in senior leadership at Capital Factory and Coyote Ventures. In 2020, Dr. Barreto noticed the underserved state of the women’s health (femtech) industry and set out to raise awareness, provide resources, and invest capital in it. She hosts the #1 femtech podcast, FemTech Focus, leads FemHealth Insights, a boutique consulting firm specializing in women’s health innovation, and authored the best-selling book “Unlocking Women’s Health, FemTech and the Quest for Gender Equity.”

Mel Mann is a retired U.S. Army major who was diagnosed with chronic myeloid leukemia in 1995, while on active duty, and given three years to live. Mel began organizing bone marrow drives, working with communities, churches, and the Department of Defense to add tens of thousands of donors to the national registry. Each donor represented hope for patients like him, though Mel never found a match for himself.

Mel was able to join a clinical trial for Gleevec, a new targeted therapy that saved his life and millions of others. As the longest-living Gleevec and Tyrosine Kinase Inhibitor survivor, Mel remains grateful for every day and continues to share his journey so others might find hope. Through speaking at conferences and community events, he encourages equal access to care, marrow donor donation, and participation in clinical trials. Mel believes that even small efforts can make a difference for someone in need.

Linda Kerrigan is Director of R&D Agile Sourcing at Bristol Myers Squibb, where she leverages over twenty years of pharmaceutical drug development expertise spanning clinical development and research. Her unique blend of procurement excellence, scientific training, and passion for continuous improvement drives strategic sourcing initiatives across BMS’s R&D portfolio. Linda’s career includes progressive roles at BMS and more than a decade at Celgene supporting clinical trial sourcing and contracting. She began her pharmaceutical career as a Research Scientist at Wyeth Vaccines Research, providing her with a scientific foundation for R&D procurement. She holds a degree in Biotechnology and an MBA in Technology Management from Rochester Institute of Technology, where she also serves on the RIT College of Science National Council, providing industry insights and advising on strategic initiatives for scientific education.